Completed NA INTERVENTIONAL 1-arm NCT03383757

U-TruSignal SpO2 Testing in Neonates

Sponsor: GE Healthcare

Interventions SpO2 Sensor application & blood draw

Updated 11 times since 2018 Last updated: Dec 3, 2020 Started: Sep 14, 2017 Primary completion: Nov 1, 2019 Completion: Nov 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Pulse Oximetry and is currently completed. GE Healthcare leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 6 earlier versions

Feb 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Aug 2019 — Feb 2020 [monthly]

Recruiting NA
Jan 2019 — Aug 2019 [monthly]

Recruiting NA
Sep 2018 — Jan 2019 [monthly]

Recruiting NA
Jun 2018 — Sep 2018 [monthly]

Recruiting NA
Jan 2018 — Jun 2018 [monthly]

Recruiting NA

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GE Healthcare

Data source: GE Healthcare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangalore, India
• Tampere, Finland